Following the two years of final stage bidding, Skanska was selected as a preferred bidder for the project, beating its rival Bouygues.
The plans for the project include a 310-bed, purpose-built hospital boasting single rooms and a research and education institute. Before the financial arrangements of PFI deal can be finalised, the project needs to be approved by Department of Health and the Treasury.
The expected start date for the construction is Autumn 2014, and the project is set to be completed by early 2017.
Skanka’s Chief Executive, Stephen Bridge, said: “This is an important milestone in the ten-year project to move to our new site on the Cambridge Biomedical Campus.
“In early October we heard that the Department of Health had cleared the business case to be forwarded to the Treasury for approval and today’s announcement will move us closer to realising our vision to provide the highest quality facilities for our patients”.
“The clinical, research and economic case for the new Papworth Hospital is beyond doubt and we look forward to relocating to the Cambridge Biomedical Campus which is fast becoming one of the most vibrant biomedical communities in the world.”
Photo: Construction Enquirer
